Construction and immunogenicity of DNA vaccine plasmids encoding four Plasmodium vivax candidate vaccine antigens

Vaccine

Volumn 17, Issue 23-24, 1999, Pages 3136-3144

  Rogers, William O ^a   Gowda, Kalpana ^a   Hoffman, Stephen L ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

DNA vaccine; Malaria; Plasmodium vivax

Indexed keywords

DNA VACCINE; MALARIA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFECT; ENZYME IMMUNOASSAY; MALARIA; MEROZOITE; MOUSE; NONHUMAN; PLASMID; PLASMODIUM VIVAX; PRIORITY JOURNAL; QUALITY OF LIFE; SPOROZOITE; TANDEM REPEAT; TARGET CELL;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; FEMALE; HUMANS; MALARIA VACCINES; MEMBRANE PROTEINS; MEROZOITE SURFACE PROTEIN 1; MICE; PLASMIDS; PLASMODIUM VIVAX; PROTOZOAN PROTEINS; TUMOR CELLS, CULTURED; VACCINES, DNA;

EID: 0033529699     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00146-2     Document Type: Article

References (34)

1. Baird J.K., Basri H., Purnomo, Bangs M.J., Subianto B., Patchen L.C., Hoffman S.L. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg. 44:1991;547-552.
2. Schuurkamp G.J., Spicer P.E., Kereu R.K., Bulungol P.K., Rieckmann K.H. Chloroquine-resistant Plasmodium vivax in Papua New Guinea. Trans R Soc Trop Med Hyg. 86:1992;121-122.
3. Myat-Phone-Kyaw, Myint-Oo, Myint-Lwin, Thaw-Zin, Kyin-Hla-Aye, Nwe-Nwe-Yin. Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). Trans R Soc Trop Med Hyg. 87:1993;687.
4. Phillips E.J., Keystone J.S., Kain K.C. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. Clin Infect Dis. 23:1996;1171-1173.
5. Doolan D.L., Hoffman S.L. Multi-gene vaccination against malaria: a multistage, multi-immune response approach. Parasitol Today. 13:1997;171-178.
6. Gordon D.M., Cosgriff T.M., Schneider I., Wasserman G.F., Majarian W.R., Hollingdale M.R., Chulay J.D. Safety and immunogenicity of a Plasmodium vivax sporozoite vaccine. Am J Trop Med Hyg. 42:1990;527-531.
7. Herrington D.A., Nardin E.H., Losonsky G., Bathurst I.C., Barr P.J., Hollingdale M.R., Edelman R., Levine M.M. Safety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax. Am J Trop Med Hyg. 45:1991;695-701.
8. Charoenvit Y., Collins W.E., Jones T.R., Millet P., Yuan L., Campbell G.H., Beaudoin R.L., Broderson J.R., Hoffman S.L. Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. Science. 251:1991;668-671.
9. Collins W.E., Nussenzweig R.S., Ballou W.R., Ruebush T.K., Nardin E.H., Chulay J.D., Majarian W.R., Young J.F., Wasserman G.F., Bathurst I., Gibson H.L., Barr P.J., Hoffman S.L., Wasserman S.S., Broderson J.R., Skinner J.C., Procell P.M., Filipski V.K., Wilson C.L. Immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivax. Am J Trop Med Hyg. 40:1989;455-464.
10. Collins W.E., Sullivan J.S., Morris C.L., Galland G.G., Jue D.L., Fang S., Wohlhueter R., Reed R.C., Yang C., Hunter R.L., Lal A.A. Protective immunity induced in squirrel monkeys with a multiple antigen construct against the circumsporozoite protein of Plasmodium vivax. Am J Trop Med Hyg. 56:1997;200-210.
11. Rosenberg R., Wirtz R.A., Lanar D.E., Sattabongkot J., Hall T., Waters A.P., Prasittisuk C. Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax. Science. 245:1989;973-976.
12. Jeffery G.M. Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium. Bull World Health Organ. 35:1966;873-882.
13. del Portillo H.A., Gysin J., Mattei D.M., Khouri E., Udagama P.V., Mendis K.N., David P.H. Plasmodium vivax: cloning and expression of a major blood-stage surface antigen. Exp Parasitol. 67:1988;346-353.
14. del Portillo H.A., Longacre S., Khouri E., David P.H. Primary structure of the merozoite surface antigen-1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species. Proc Natl Acad Sci USA. 88:1991;4030-4034.
15. Cheng Q., Saul A. Sequence analysis of the apical membrane antigen I (AMA-1) of Plasmodium vivax. Mol Biochem Parasitol. 65:1994;183-187.
16. Fang X.D., Kaslow D.C., Adams J.H., Miller L.H. Cloning of the Plasmodium vivax Duffy receptor. Mol Biochem Parasitol. 44:1991;125-132.
17. Doolan DL, Hedstrom RC, Gardner MJ, Sedegah M, Gramzinski RA, Wang H, Margalith M, Hobart P, Hoffman SL, DNA vaccination as an approach to malaria control: current status and strategies, Curr Top Microbiol Immunol 1998;226:37-56.
18. Holder A.A. The precursor to major merozoite surface antigens: structure and role in immunity. Prog Allergy. 41:1988;72-97.
19. Templeton T.J., Kaslow D.C. Cloning and cross-species comparison of the Thrombospondin-related anonymous protein (TRAP) gene from Plasmodium knowlesi, Plasmodium vivax, and Plasmodium gallinaceum. Mol Biochem Parasitol. 84:1997;13-25.
20. Hartikka J., Sawdey M., Cornefert Jensen F., Margalith M., Barnhart K., Nolasco M., Vahlsing H.L., Meek J., Marquet M., Hobart P., Norman J., Manthorpe M. An improved plasmid DNA expression vactor for direct injection into skeletal muscle. Hum Gene Ther. 7:1996;1205-1217.
21. Luke C.J., Carner K., Liang X., Barbour A.G. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi. J Infect Dis. 175:1997;91-97.
22. Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M.D., Silverman G.J., Lotz M., Carson D.A., Raz E. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science. 273:1996;352-354.
23. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., Northrop J.P., Rongold G.M., Danielsen M. Lipofectin: a highly efficient, lipid-mediated DNA transfection procedure. Proc Natl Acad Sci USA. 84:1987;7413-7417.
24. Arnot D.E., Barnwell J.W., Stewart M.J. Does biased gene conversion influence polymorphism in the circumsporozoite protein-encoding gene of Plasmodium vivax? Proc Natl Acad Sci USA. 85:1988;8102-8106.
25. De La Cruz V.F., Lal A.A., Welsh J.A., McCutchan T.F. Evolution of the immunodominant domain of the circumsporozoite protein gene from Plasmodium vivax. J Biol Chem. 262:1987;6464-6467.
26. Arnot D.E., Barnwell J.W., Tam J.P., Nussenzweig V., Nussenzweig R.S., Enea V. Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitope. Science. 230:1985;815-818.
27. Hedstrom R.C., Campbell J.R., Leef M.L., Charoenvit Y., Carter M., Sedegah M., Beaudoin R.L., Hoffman S.L. A malaria sporozoite surface antigen distinct from the circumsporozoite protein. Bull World Health Organ. 68:(Suppl.):1990;152-157.
28. Rogers W.O., Malik A., Mellouk S., Nakamura K., Rogers M.D., Szarfman A., Gordon D.M., Nussler A.K., Aikawa M., Hoffman S.L. Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc Natl Acad Sci USA. 89:1992;9176-9180.
29. Herrera M.A., de Plata C., Gonzalez J.M., Corradin G., Herrera S. Immunogenicity of multiple antigen peptides containing Plasmodium vivax CS epitopes in BALB/c mice. Mem Inst Oswaldo Cruz. 89:(Suppl 2):1994;71-76.
30. Herrera S., de Plata C., Gonzalez J.M., Perlaza B.L., Bettens F., Corradin G., Arevalo Herrera M. Antigenicity and immunogenicity of multiple antigen peptides (MAP) containing P. vivax CS epitopes in Aotus monkeys. Parasite Immunol. 19:1997;161-170.
31. Yang C., Collins W.E., Xiao L., Saekhou A.M., Reed R.C., Nelson C.O., Hunter R.L., Jue D.L., Fang S., Wohlhueter R.M., Udhayakumar V., Lal A.A. Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite repeat region and a universal T helper epitope of tetanus toxin. Vaccine. 15:1994;377-386.
32. Sedegah M., Hedstrom R., Hobart P., Hoffman S.L. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc Natl Acad Sci USA. 91:1994;9866-9870.
33. Hoffman S.L., Sedegah M., Hedstrom R.C. Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine. Vaccine. 12:1994;1529-1533.
34. Charoenvit Y., Mellouk S., Cole C., Bechara R., Leef M.F., Sedegah M., Yuan L.F., Robey F.A., Beaudoin R.L., Hoffman S.L. Monoclonal, but not polyclonal antibodies protect against Plasmodium yoelii sporozoites. J Immunol. 146:1991;1020-1025.